Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Biomea Fusion, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
01/12/2023 8-K Investor presentation
Docs: "Biomea Fusion to Present at 41st Annual J.P. Morgan Healthcare Conference and Highlight 2023 Corporate Milestones REDWOOD CITY, Calif., Jan. 9, 2023 — Biomea Fusion, Inc. , a clinical-stage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients with genetically defined cancers and metabolic diseases, today announced that Thomas Butler, Biomea Fusion's Chief Executive Officer and Chairman of the Board, will present recent progress and 2023 corporate milestones at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 from 11:15 - 11:55 am ET, and that Biomea management will hold 1x1 meetings during the conference January 9 - 11. A live webcast of the presentation will be available ...",
"Corporate Slide Presentation of Biomea Fusion, Inc., titled “JP Morgan 2023 Corporate Presentation”"
12/13/2022 8-K Investor presentation
Docs: "Biomea Fusion Presents at the 2022 ASH Annual Meeting Preclinical Data on BMF-500 Supporting its Potential as the Most Potent and Selective FLT3 Inhibitor to Date",
"Presentation titled, “BMF-500: An Orally Bioavailable Covalent Inhibitor of FLT3 with High Selectivity and Potent Antileukemic Activity in FLT3-Mutated AML.”"
01/12/2022 8-K Investor presentation
Docs: "Corporate Slide Presentation of Biomea Fusion, Inc. dated January 2022",
"Corporate Slide Presentation of Biomea Fusion, Inc. dated January 2022"
11/15/2021 8-K Investor presentation
Docs: "Corporate Slide Presentation of Biomea Fusion, Inc. dated November 2021"
07/19/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy